Bradycardia – Evidence‑Based Guideline Summary

Definition & Classification

• Bradycardia is defined as a heart rate < 50 beats per minute when clinically significant and is broadly classified into sinus node dysfunction (SND) and atrioventricular (AV) block. 1, 2

• Sinus node dysfunction manifestations (all supported by the same source):

  • Sinus bradycardia – sinus rate < 50 bpm with normal P‑wave morphology. 2
  • Ectopic atrial bradycardia – atrial depolarization from a non‑sinus pacemaker with rate < 50 bpm. 2
  • Sinoatrial exit block – blocked conduction between sinus node and atrial tissue, producing “group beating” and sinus pauses. 2
  • Sinus pause – pause > 3 seconds after the preceding atrial depolarization. 2
  • Sinus node arrest – absence of sinus depolarization for a prolonged interval. 2
  • Tachycardia‑bradycardia syndrome – alternating sinus or ectopic bradycardia with atrial tachyarrhythmias (flutter/fibrillation). 2
  • Chronotropic incompetence – failure to achieve ≥ 80 % of predicted heart‑rate reserve during exercise. 2
  • Isorhythmic dissociation – atrial rate slower than ventricular rate originating from AV node, His bundle, or ventricular focus. 2

• AV‑block classification (supported by both sources):

  • First‑degree AV block – 1:1 AV conduction with PR interval > 200 ms (AV delay, not true block). 2
  • Mobitz I (Wenckebach) – progressive PR prolongation culminating in a dropped P‑wave at a constant atrial rate < 100 bpm. 2
  • Mobitz II – constant PR intervals with intermittent non‑conducted P‑waves at a constant atrial rate < 100 bpm. 2
  • 2:1 AV block – every other P‑wave conducts. 2
  • Advanced (high‑grade) second‑degree AV block – ≥ 2 consecutive non‑conducted P‑waves. 2
  • Third‑degree (complete) AV block – complete dissociation of atrial and ventricular rhythms. 1, 2

• Escape rhythms (when higher pacemakers fail):

  • Junctional rhythm – AV‑junction escape rate ≈ 40‑60 bpm. 1, 2
  • Ventricular escape rhythm – ventricular escape rate < 40 bpm with wide QRS complexes. 1, 2

Etiology (Reversible & Irreversible)

• Infiltrative diseases (e.g., sarcoidosis, amyloidosis, hemochromatosis) can impair conduction and cause bradycardia. 1, 2
• Inflammatory conditions (myocarditis, Lyme disease, rheumatic fever) are recognized reversible contributors. 1, 2
• Congenital structural heart disease may involve the conduction system and precipitate bradyarrhythmias. 1, 2
• Medications—including β‑blockers, non‑dihydropyridine calcium‑channel blockers, digoxin, amiodarone, sotalol, and ivabradine—are common reversible causes. 3
• Increased vagal tone (e.g., in athletes, during sleep, or vasovagal episodes) can produce bradycardia. 4, 1

Clinical Presentation

• Symptomatic bradycardia is defined as documented bradyarrhythmia directly causing syncope, presyncope, dizziness, heart‑failure symptoms, or cerebral hypoperfusion‑related confusion. 1, 2, 5

• Presentation varies according to:

  • Type of bradycardia (sinus vs. AV block vs. escape rhythm) 5
  • Ventricular rate and duration of pauses 4
  • Whether the abnormality is fixed or intermittent 2
  • Co‑existing medical conditions 2
  • Concomitant medications 3
• Vagally mediated AV block occurring during sleep may be asymptomatic, identified by concurrent sinus slowing (P‑P prolongation). 1, 2, 5
• Sudden parasympathetic surges (vasovagal syncope) can produce symptomatic bradycardia. 1, 2, 5

Diagnostic Evaluation

• 12‑lead ECG is essential to determine:

  • Type of bradycardia (sinus, AV block, escape rhythm). 1, 2
  • Degree of AV block (e.g., first‑degree, Mobitz I/II, complete). 6
  • QRS morphology (narrow vs. wide) indicating level of block. 1
  • Presence of additional conduction disease (bundle‑branch or fascicular blocks). 1

• Ambulatory monitoring (24‑h Holter or event recorder) is required to:

  • Correlate symptoms with rhythm disturbances. 1, 2, 3
  • Detect intermittent bradyarrhythmias. 1, 2, 3

• Exercise testing helps assess:

  • Resolution of bradycardia with sympathetic activation. 1, 2
  • Chronotropic competence. 1, 2
  • Rare exercise‑induced AV block. 6

• Physiologic vs. pathologic bradycardia in athletes is confirmed when:

  • No symptoms (dizziness, syncope).
  • Heart rate normalizes during exercise with preserved maximal rate.
  • Bradycardia reverses after reduction of training. 4

• First‑degree AV block and Mobitz I in athletes are considered physiologic if they resolve with hyperventilation or exercise. 4

Acute Management of Unstable Bradycardia

• Atropine 0.5‑1 mg IV is first‑line; may be ineffective for infranodal block. 3
• Temporary pacing (transcutaneous or transvenous) is indicated when pharmacologic therapy fails. 6
• Catecholamines (dopamine, epinephrine) are alternatives if pacing is unavailable. 6

Management of Reversible Causes

• Discontinue or reduce offending drugs (β‑blockers, calcium‑channel blockers, digoxin, antiarrhythmics). 4
• Correct metabolic abnormalities (thyroid hormone replacement, electrolyte normalization). 6
• Treat hypoxemia promptly. 3
• Manage obstructive sleep apnea when suspected. 4

Permanent Pacemaker Indications

Class I (Definite)

• Symptomatic sinus node dysfunction with documented brady‑related symptoms. 3
• Symptomatic third‑degree (complete) AV block. 6
• Mobitz II second‑degree AV block (even if asymptomatic) due to high risk of progression. 3
• Bifascicular block with intermittent complete heart block and symptomatic bradycardia. 6

Class II (Reasonable)

• Bifascicular or trifascicular block with syncope when complete block is not documented and other causes have been excluded. 6
• Markedly prolonged HV interval (> 100 ms) on electrophysiology study. 6

Class III (Not Indicated)

• Asymptomatic sinus node dysfunction, even with heart rate < 40 bpm. 6
• Asymptomatic first‑degree AV block. 6
• Asymptomatic Mobitz I (Wenckebach) second‑degree AV block. 3
• Bradycardia clearly unrelated to symptoms. 6

Special Populations

Athletes

• First‑degree AV block (≈ 35 % prevalence) and Mobitz I (≈ 10 % prevalence) are common and require no intervention if they resolve with exercise. 4
• Mobitz II and third‑degree AV block are rare in athletes and warrant careful diagnostic evaluation. 4

Tachycardia‑Bradycardia Syndrome

• Patients often need permanent pacing combined with antiarrhythmic therapy to control the tachyarrhythmic component. 6, 3

Common Pitfalls & Caveats

• Permanent pacemakers should not be implanted for asymptomatic bradycardia regardless of heart‑rate magnitude. 3
• Always exclude reversible etiologies (medications, thyroid dysfunction, electrolyte disturbances, hypoxemia) before proceeding to permanent pacing. 4, 3
• Nonspecific symptoms such as fatigue are multifactorial and may not correlate with modest bradycardia. 1, 2, 5
• In vasovagal syncope, bradycardia is frequently accompanied by a vasodepressor response; pacing alone is insufficient. 1, 2, 5
• Temporary pacing may be required while treating reversible causes in hemodynamically stable patients to avoid unnecessary permanent implantation. 6, 3

Bradycardia Diagnosis and Management

Types of Bradycardia

• The American College of Cardiology defines bradycardia as a heart rate <50 beats per minute when clinically significant, and it is broadly classified into two main types: sinus node dysfunction (SND) and atrioventricular (AV) block 7
• Sinus node dysfunction encompasses disorders of impulse formation and includes several distinct electrocardiographic manifestations, such as sinus bradycardia, which is characterized by a sinus rate <50 bpm with normal P-wave morphology 7
• The American College of Cardiology recommends that ectopic atrial bradycardia, characterized by atrial depolarization from a pacemaker other than the sinus node with rate <50 bpm, be recognized as a distinct type of bradycardia 7
• Sinoatrial exit block is a condition where there is blocked conduction between the sinus node and adjacent atrial tissue, manifesting as "group beating" of atrial depolarization and sinus pauses, according to the American College of Cardiology 7
• Sinus pause is defined as the sinus node depolarizing >3 seconds after the last atrial depolarization, as stated by the American College of Cardiology 7
• The American College of Cardiology defines sinus node arrest as no evidence of sinus node activity for prolonged periods 7
• Chronotropic incompetence is the failure to reach a target heart rate with exertion, typically defined as failure to reach 80% of expected heart rate reserve, calculated as [220 - age] minus resting heart rate, according to the American College of Cardiology 7

Causes of Bradycardia

• The American Heart Association states that degenerative fibrosis of the conduction system is the most common cause of intrinsic cardiac disease leading to bradycardia in the elderly 7
• Ischemic heart disease and myocardial infarction, particularly inferior MI affecting the AV node, can cause bradycardia, as reported in Circulation 8
• The American College of Cardiology recommends screening for hypothyroidism with thyroid function tests in patients with bradycardia 9
• Electrolyte abnormalities, particularly hyperkalemia and hypomagnesemia, can cause bradycardia, according to the American College of Cardiology 9
• Hypoxemia is a common and reversible cause of bradycardia that should be assessed immediately, as stated by Circulation 8
• Obstructive sleep apnea should be screened if bradycardia occurs during sleep or risk factors are present, according to the American College of Cardiology 9
• Beta-blockers, calcium channel blockers, digoxin, and antiarrhythmic drugs can cause bradycardia, as reported by the American College of Cardiology and Circulation 9, 8
• Ivabradine can cause bradycardia, according to the American College of Cardiology 9

Diagnosis and Treatment

• The American College of Cardiology states that the key determinant for treatment is not the absolute heart rate number, but rather the correlation between bradycardia and symptoms 9
• Asymptomatic sinus bradycardia, even with rates as low as 37-40 bpm, requires no treatment and has a benign prognosis, according to the American College of Cardiology 9
• Symptomatic bradycardia, defined as documented bradyarrhythmia directly causing syncope, presyncope, dizziness, heart failure symptoms, or confusional states from cerebral hypoperfusion, requires intervention, as stated by the American College of Cardiology and Circulation 7, 10
• The American College of Cardiology recommends that treating asymptomatic bradycardia based solely on heart rate is not indicated in the absence of symptoms 9
• Failing to identify reversible causes, such as medications, thyroid function, electrolytes, and hypoxemia, before considering permanent pacing is a common pitfall, according to the American College of Cardiology 9